# The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial)

> **NCT05391802** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** Transcatheter mitral valve repair

## Key facts

- **NCT ID:** NCT05391802
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-30
- **Primary completion:** 2022-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391802, "The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05391802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*